SCHEMBL4905286

SCHEMBL4905286

CCN(Sc1ccc(C(C)C)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 4/20 0.34
KDM4E B2RXH2 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MCL1 Q07820 2/20 0.33
BCHE P06276 2/20 0.33
ACHE P22303 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
BMP1 P13497 2/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
LMNA P02545 3/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903996 0.89 LMNA (0.33) TSHRALDH1A1MCL1BCHEACHE
SCHEMBL4906296 0.88 ALDH1A1 (0.48) TSHRALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL4905008 0.88 TSHR (0.42) TSHRALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL4902795 0.88 ALDH1A1 (0.42) TSHRALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL4906634 0.85 ALDH1A1 (0.40) TSHRALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL4902983 0.84 ALDH1A1 (0.39) TSHRALDH1A1KDM4ESMN1; SMN2MCL1
SCHEMBL4904210 0.84 KDM4E (0.40) TSHRALDH1A1KDM4ESMN1; SMN2CYP2C19
SCHEMBL4908910 0.84 ALDH1A1 (0.39) TSHRALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL4902927 0.84 ALDH1A1 (0.48) TSHRALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL4907051 0.84 ALDH1A1 (0.41) TSHRALDH1A1KDM4ESMN1; SMN2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD TSHR 412/4885ALDH1A1 2664/4885MAPT 1858/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TSHR 400/4885ALDH1A1 2956/4885MAPT 1786/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TSHR 400/4885ALDH1A1 2956/4885MAPT 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.